Thomas J. Schuetz Compass Therapeutics, Inc. (CMPX) insider trading activity

CMPX Quotes by TradingView

Thomas J. Schuetz is CEO of Compass Therapeutics, Inc.. Currently has a direct ownership of 6.69 Million shares of CMPX, which is worth approximately $32.6 Million. The most recent transaction as insider was on Jun 01, 2022, when has been sold 20,000 shares (Common Stock) at a price of $3.03 per share, resulting in proceeds of $60,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.69M
3.18% 3M change
2.68% 12M change
Total Value Held $32.6 Million

Thomas J. Schuetz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2022
BUY
Open market or private purchase
$60,600 $3.03 p/Share
20,000 Added 0.38%
5,231,873 Common Stock
May 26 2022
BUY
Open market or private purchase
$60,800 $3.04 p/Share
20,000 Added 0.38%
5,211,873 Common Stock
May 23 2022
BUY
Open market or private purchase
$49,926 $2.72 p/Share
18,355 Added 0.35%
5,191,873 Common Stock
May 17 2022
BUY
Open market or private purchase
$49,931 $2.47 p/Share
20,215 Added 0.39%
5,173,518 Common Stock
May 10 2022
BUY
Open market or private purchase
$50,105 $1.8 p/Share
27,836 Added 0.54%
5,153,303 Common Stock
Nov 16 2021
BUY
Grant, award, or other acquisition
-
600,000 Added 10.48%
5,125,467 Common Stock
TJS

Thomas J. Schuetz

CEO
Boston, MA

Track Institutional and Insider Activities on CMPX

Follow Compass Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CMPX shares.

Notify only if

Insider Trading

Get notified when an Compass Therapeutics, Inc. insider buys or sells CMPX shares.

Notify only if

News

Receive news related to Compass Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CMPX